Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.43 | N/A |
PEG Ratio (TTM) | 2.33 | N/A |
P/S Ratio (TTM) | 2.82 | N/A |
P/B Ratio (TTM) | 1.23 | N/A |
P/FCF Ratio (TTM) | -12.01 | N/A |
Price to 5YR AVG Earnings Ratio | -2.05 | N/A |
Price to 5YR AVG FCF Ratio | -4.41 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -32.05% | N/A |
ROE (TTM) | -49.28% | N/A |
Net Profit Margin (TTM) | -115.46% | N/A |
ROIC 5YR AVG | -107.28% | N/A |
Growth (17%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -2.51% | -101.21% | -98.07% |
Revenue | -2.40% | 117.27% | 59.11% |
Net Income | -4.83% | -121.18% | -85.82% |
Cash Flow | -237.05% | -166.24% | -201.96% |
Health (21%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.36 | N/A |
Quick Ratio (TTM) | 0.35 | N/A |
D/E Ratio (TTM) | 0.03 | N/A |
Interest Coverage (TTM) | -881.56 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.17 | N/A |
Shares Outstanding Growth 5YR AVG | 79.19% | N/A |